FEATURED NEWS
Reminder: 4 days to Brexit Event!
Our CEO Ann McGee will be speaking at the Pharma and Brexit Conference – hosted by PDA Ireland and PDA United Kingdom.
The event will focus on the impact, challenges and solutions for the pharmaceutical industry.
Annex 21 in Effect from August 21st 2022
The new Annex 21, The Rules Governing Medicinal Products in the European Union Volume 4 EU Guidelines for Good Manufacturing Practice
BREXIT – Impact, Challenges and Solutions for the Pharmaceutical Industry
Our CEO Ann McGee will be speaking at the Pharma and Brexit Conference - hosted by PDA Ireland and PDA United Kingdom. The event will
Extension of the comment period by FDA
FDA Proposed Rule "National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers" In February 2022, the FDA has
Regulations for Pharmaceuticals Post Brexit
The European Commission has published a Communication to prepare for the end of the transition period. The document is appropriately entitled "Getting ready for
BREXIT – Impact, Challenges and Solutions for the Pharmaceutical Industry
Our CEO Ann McGee will be speaking at the Pharma and Brexit Conference - hosted by PDA Ireland and PDA United
Extension of the comment period by FDA
FDA Proposed Rule "National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers" In February
GMP/GDP Audits & the Importance of CAPA
The conduct of audits is a key part of our Pharmaceutical Quality Systems to give us information
Merry Christmas and Happy New Year
MIAS has continued exceptional growth and development over 2021. We'd like to thank our Team, Customers and Suppliers for contributing to the continued success
Welcome to the Team
We would like to welcome Ciara Kearney, Lisa Evans, Sherry A Calimlim and Olivia McEvoy to the MIAS Pharma Team. They are a very welcome
Good Practices for Data Management and Integrity
The pharmaceutical industry is underpinned by a large amount of documentation to show evidence of the quality, safety and efficacy of the drug product